Clinical Trial Update: Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing acyclovir-penciclovir cream to Abreva for suppression of herpes simplex eruptions has completed, reporting efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Virus Infections

Drugs mentioned

• ABREVA (Docosanol)
• Acyclovir-penciclovir cream

Snippet

Sponsor: University of Utah | Conditions: Herpes Simplex Oral | Phase 2 | Status: COMPLETED